632 related articles for article (PubMed ID: 15717060)
21. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.
Löscher W; Luna-Tortós C; Römermann K; Fedrowitz M
Curr Pharm Des; 2011; 17(26):2808-28. PubMed ID: 21827408
[TBL] [Abstract][Full Text] [Related]
22. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.
Eisenblätter T; Hüwel S; Galla HJ
Brain Res; 2003 May; 971(2):221-31. PubMed ID: 12706238
[TBL] [Abstract][Full Text] [Related]
23. Membrane transporter proteins: a challenge for CNS drug development.
Girardin F
Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
[TBL] [Abstract][Full Text] [Related]
24. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.
Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK
Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525
[TBL] [Abstract][Full Text] [Related]
25. Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human.
Warren MS; Zerangue N; Woodford K; Roberts LM; Tate EH; Feng B; Li C; Feuerstein TJ; Gibbs J; Smith B; de Morais SM; Dower WJ; Koller KJ
Pharmacol Res; 2009 Jun; 59(6):404-13. PubMed ID: 19429473
[TBL] [Abstract][Full Text] [Related]
26. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
Assaraf YG
Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
[TBL] [Abstract][Full Text] [Related]
27. ATP-binding cassette (ABC) drug transporters in the developing blood-brain barrier: role in fetal brain protection.
Eng ME; Imperio GE; Bloise E; Matthews SG
Cell Mol Life Sci; 2022 Jul; 79(8):415. PubMed ID: 35821142
[TBL] [Abstract][Full Text] [Related]
28. Role of breast cancer resistance protein (BCRP) as active efflux transporter on blood-brain barrier (BBB) permeability.
Garg P; Dhakne R; Belekar V
Mol Divers; 2015 Feb; 19(1):163-72. PubMed ID: 25502234
[TBL] [Abstract][Full Text] [Related]
29. Disease-Induced Modulation of Drug Transporters at the Blood-Brain Barrier Level.
Al Rihani SB; Darakjian LI; Deodhar M; Dow P; Turgeon J; Michaud V
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916769
[TBL] [Abstract][Full Text] [Related]
30. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
[TBL] [Abstract][Full Text] [Related]
31. Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS.
Jablonski MR; Jacob DA; Campos C; Miller DS; Maragakis NJ; Pasinelli P; Trotti D
Neurobiol Dis; 2012 Aug; 47(2):194-200. PubMed ID: 22521463
[TBL] [Abstract][Full Text] [Related]
32. Regulation of ABC transporters at the blood-brain barrier: new targets for CNS therapy.
Hartz AM; Bauer B
Mol Interv; 2010 Oct; 10(5):293-304. PubMed ID: 21045243
[TBL] [Abstract][Full Text] [Related]
33. Altered glycaemia differentially modulates efflux transporter expression and activity in hCMEC/D3 cell line.
Sajja RK; Cucullo L
Neurosci Lett; 2015 Jun; 598():59-65. PubMed ID: 25982326
[TBL] [Abstract][Full Text] [Related]
34. ABC Transporters and Drug Resistance in Patients with Epilepsy.
Feldmann M; Koepp M
Curr Pharm Des; 2016; 22(38):5793-5807. PubMed ID: 27514707
[TBL] [Abstract][Full Text] [Related]
35. Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein.
Lee YJ; Kusuhara H; Jonker JW; Schinkel AH; Sugiyama Y
J Pharmacol Exp Ther; 2005 Jan; 312(1):44-52. PubMed ID: 15448171
[TBL] [Abstract][Full Text] [Related]
36. Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2.
Bakhsheshian J; Wei BR; Chang KE; Shukla S; Ambudkar SV; Simpson RM; Gottesman MM; Hall MD
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20801-6. PubMed ID: 24297888
[TBL] [Abstract][Full Text] [Related]
37. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
Leslie EM; Deeley RG; Cole SP
Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
[TBL] [Abstract][Full Text] [Related]
38. Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection.
Ronaldson PT; Persidsky Y; Bendayan R
Glia; 2008 Dec; 56(16):1711-35. PubMed ID: 18649402
[TBL] [Abstract][Full Text] [Related]
39. Re-evaluation of the hCMEC/D3 based in vitro BBB model for ABC transporter studies.
Balzer V; Poc P; Puris E; Martin S; Aliasgari M; Auriola S; Fricker G
Eur J Pharm Biopharm; 2022 Apr; 173():12-21. PubMed ID: 35227855
[TBL] [Abstract][Full Text] [Related]
40. The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2).
Römermann K; Helmer R; Löscher W
Neuropharmacology; 2015 Jun; 93():7-14. PubMed ID: 25645391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]